GURU.Markets stock price, segment price, and overall market index valuation
The company's share price CapsoVision Inc
CapsoVision, a developer of innovative capsule endoscopy, is valued based on its technological advantages. Its potential share price will depend on regulatory approvals and the successful launch of its product into the competitive medical device market.
Share prices of companies in the market segment - Diagnostic medical equipment
CapsoVision is an innovative medical company that developed the CapsoCam Plus capsule endoscopy system, which allows for comfortable small bowel examinations. We've categorized it as "Diagnostic Equipment," and the chart below shows the dynamics within the medical technology sector.
Broad Market Index - GURU.Markets
The Central Fund of Canada is a financial instrument that invests in physical gold and silver, providing investors with a convenient way to own precious metals. It is included in the GURU.Markets index. The chart below shows the market. See how this fund's shares correlate with gold and silver prices.
Change in the price of a company, segment, and market as a whole per day
CV - Daily change in the company's share price CapsoVision Inc
For CapsoVision, a developer of endoscopic capsules, change_co is a measure of innovation volatility. Daily fluctuations reflect sales news and technological breakthroughs. This metric forms the basis for analyzing medical technology companies on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Diagnostic medical equipment
The medical device sector in which CapsoVision Inc operates is highly dynamic. This chart reflects the industry's average volatility. It serves as a benchmark for assessing how sensitive CapsoVision's capsule endoscopy business is to overall trends and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
CapsoVision is a private company that has developed innovative capsule endoscopy. Its potential IPO will depend heavily on the market's appetite for medical technology innovation. The chart below shows the general volatility that affects the fate of such "unicorns."
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization CapsoVision Inc
CapsoVision Inc.'s year-over-year performance is a story of the introduction of its innovative capsule endoscopy system. Its 12-month market cap reflects the success of its CapsoCam capsule, which provides a 360-degree view of the small intestine, a key competitive advantage that could change diagnostic standards.
Annual dynamics of market capitalization of the market segment - Diagnostic medical equipment
CapsoVision, a privately held company, offers innovative capsule endoscopy. Its growth depends on hospital adoption of its technology as a less invasive alternative. Its valuation is likely outpacing the medical device sector, reflecting the potential of its disruptive technology.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
CapsoVision is privately held and not publicly traded. Its market performance cannot be analyzed. As the developer of an innovative endoscopic capsule, its business is at the forefront of medical technology. Its success is determined by clinical data and its ability to bring the product to market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization CapsoVision Inc
CapsoVision's growth as a medical diagnostics company will depend on the adoption of its technology. Monthly fluctuations on the chart will reflect the growth in the number of procedures using its esophageal capsule endoscopy system.
Monthly dynamics of market capitalization of the market segment - Diagnostic medical equipment
CapsoVision has developed an innovative endoscopic capsule for gastrointestinal tract examination. The medical diagnostic equipment sector is driven by a desire for less invasive and more accurate methods. The chart below shows how investors valued companies offering breakthrough technologies for early disease diagnosis.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
CapsoVision, as a developer of medical diagnostic equipment, depends on the adoption of its technologies in clinical practice. Its stock performance is determined by sales volumes, regulatory approvals, and the competitive environment, rather than general economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization CapsoVision Inc
Shares of CapsoVision, a developer of an endoscopic capsule for diagnostics, reflect advances in medical imaging. Weekly price movements depend on sales news, regulatory approvals, and competition in this niche. The chart below shows how short-term developments in the medical technology sector impact the company's valuation.
Weekly dynamics of market capitalization of the market segment - Diagnostic medical equipment
How does CapsoVision's performance compare to the overall medical device market? This chart compares the endoscopic capsule developer's weekly stock price movements to the sector average. This helps us understand whether its reaction to sales and regulatory approvals is typical, or whether its niche technology is creating a unique trajectory.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
CapsoVision produces an endoscopic capsule for esophageal examination. This chart compares its weekly performance to the market. It helps understand what's driving the stock: the general trend in medical technology or news about the clinical implementation of its innovative technology, which is key to its growth.
Market capitalization of the company, segment and market as a whole
CV - Market capitalization of the company CapsoVision Inc
The CapsoVision Inc. valuation chart represents the company's innovative capsule endoscopy system, which allows doctors to visualize the small intestine without invasive procedures. The company's market cap depends on how widely its technology is adopted in gastroenterology. Its performance reflects the potential and challenges on the path to a new diagnostic standard.
CV - Share of the company's market capitalization CapsoVision Inc within the market segment - Diagnostic medical equipment
CapsoVision Inc is a company whose market share and market capitalization are based on its innovative capsule endoscopy, which provides a 360-degree view for diagnosing small bowel diseases.
Market capitalization of the market segment - Diagnostic medical equipment
The graph illustrates the overall value of the gastroenterology diagnostic equipment market. CapsoVision, with its capsule endoscopy technology, is an innovator. The dynamics in the chart show how new, less invasive technologies are gaining share in this conservative market.
Market capitalization of all companies included in a broad market index - GURU.Markets
This graph depicts the market valuation of innovations in gastroenterology. CapsoVision's market capitalization stems from its belief in its capsule endoscopic system, which makes gastrointestinal examinations less invasive. The line shows how new diagnostic technologies are competing for market share in the global medical device industry.
Book value capitalization of the company, segment and market as a whole
CV - Book value capitalization of the company CapsoVision Inc
The chart below shows the value of CapsoVision's technological foundation. Its assets include patents and manufactured CapsoCam Plus® endoscopic capsules, which are used for small intestinal imaging. The trend shows the company's investment in the development and commercialization of this innovative diagnostic technology.
CV - Share of the company's book capitalization CapsoVision Inc within the market segment - Diagnostic medical equipment
CapsoVision's tangible assets include its production lines for assembling innovative endoscopic capsules for gastrointestinal examinations. The chart shows the company's share of this high-tech medical infrastructure, which offers a less invasive alternative to traditional endoscopy.
Market segment balance sheet capitalization - Diagnostic medical equipment
Below you can see the overall book value of the medical equipment sector. In this context, CapsoVision, with its endoscopic capsule, is capital-intensive. The development and production of such a complex medical device requires significant investment in R&D and precision manufacturing.
Book value of all companies included in the broad market index - GURU.Markets
CapsoVision has developed innovative capsule endoscopy. The company's assets aren't hospitals, but the technology and manufacturing facilities used to create these "pill-shaped cameras." The company's balance sheet is the value of a less invasive way to peer inside a real human body.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - CapsoVision Inc
CapsoVision's balance sheet is the value of its production assets. Its market capitalization is a bet on the success of its capsule endoscopy technology. The MvsBCap_Co chart shows how investors value its innovative product relative to its production costs.
Market to book capitalization ratio in a market segment - Diagnostic medical equipment
CapsoVision has developed innovative capsule endoscopy, which allows doctors to examine the small intestine without invasive procedures. Its value lies in the technology. The chart shows how the market views its medical device and its potential to become a standard in gastroenterology.
Market to book capitalization ratio for the market as a whole
CapsoVision has developed an innovative capsule endoscopic system for small bowel examination that requires no external equipment. The company's value lies in its unique medical technology. This chart helps explain why the medical technology sector often trades at a premium to its book value.
Debts of the company, segment and market as a whole
CV - Company debts CapsoVision Inc
CV is the ticker symbol for CapsoVision Inc. As a manufacturer of medical devices, particularly endoscopy capsules, the company likely uses debt for R&D, production, and commercialization. This chart would reflect how it raises funds to bring innovative diagnostic tools to market, which requires significant upfront investment.
Market segment debts - Diagnostic medical equipment
CapsoVision has developed an innovative capsule endoscopy system that allows doctors to examine the small intestine without invasive procedures. This chart illustrates how the medical technology company is funding the production and commercialization of its product while competing in the diagnostic equipment market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio CapsoVision Inc
CapsoVision produces an innovative capsule endoscopy system for diagnosing gastrointestinal diseases. This chart shows how much the company relies on debt to bring its product to market. In the medical device sector, debt becomes a risk if the process of obtaining insurance approval and clinical implementation is delayed.
Market segment debt to market segment book capitalization - Diagnostic medical equipment
CapsoVision has developed an innovative capsule endoscopy system for small intestinal imaging. Bringing new medical devices to market is an expensive process. The chart shows how the company's debt load, aimed at commercialization, relates to the market capitalization of the medical device sector.
Debt to book value of all companies in the market
CapsoVision (CV) develops and markets an innovative capsule endoscopic system for small bowel imaging. This represents a breakthrough in medical diagnostics. This chart shows the overall market leverage. It helps explain why medical technology companies may be very cautious about leverage during the commercialization phase of their products.
P/E of the company, segment and market as a whole
P/E - CapsoVision Inc
This chart shows the valuation of CapsoVision, a company that developed an endoscopic capsule for esophageal examination. The P/E (if positive) will depend on the pace of adoption of this less invasive technology in gastroenterology practice. The valuation is a bet that its product will become a diagnostic standard.
P/E of the market segment - Diagnostic medical equipment
This is the average P/E for medical device manufacturers. For CapsoVision, with its innovative capsule endoscopy system, this is an important benchmark. It helps understand how investors view its potential to disrupt the diagnostics market compared to larger companies with established technologies.
P/E of the market as a whole
CapsoVision develops an innovative capsule endoscopy system that allows doctors to examine the small intestine without invasive procedures. The company's capsule offers a unique 360-degree view. This chart, reflecting overall sentiment, helps understand how investors view companies offering breakthrough solutions in medical diagnostics.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company CapsoVision Inc
CapsoVision has developed an innovative capsule endoscopy system for examining the small intestine, providing a 360-degree view without the need for an external recording device. This graph shows the expected adoption of this more patient-friendly technology. The assessment depends on its acceptance by physicians and its competition with other diagnostic methods.
Future (projected) P/E of the market segment - Diagnostic medical equipment
CapsoVision has developed an innovative capsule endoscopic system for small bowel examination. This chart compares the company's future profitability expectations with those of the medical device industry. It reflects the market's confidence that their patient-friendly technology will find widespread application in gastroenterology.
Future (projected) P/E of the market as a whole
CapsoVision has developed an innovative capsule endoscopy system that allows for non-invasive examination of the small intestine. The company's success depends on the adoption of its technology in medical practice. This market pressure impacts CapsoVision through clinic budgets, which are more willing to invest in new equipment during periods of economic growth.
Profit of the company, segment and market as a whole
Company profit CapsoVision Inc
CapsoVision has developed an innovative capsule endoscopic system that allows doctors to examine the small intestine without invasive procedures. Patients simply swallow a capsule containing a camera. The company's profits depend on the adoption of this technology in medical practice.
Profit of companies in the market segment - Diagnostic medical equipment
CapsoVision has developed capsule endoscopy—a ingestible camera for examining the small intestine. The technology offers a less invasive alternative to traditional methods. This chart for the medical device sector illustrates how innovations focused on patient comfort and convenience can create new markets and impact overall industry profitability.
Overall market profit
CapsoVision has developed an innovative capsule endoscopy system for examining the small intestine. The company's success depends on the adoption of its technology in clinical practice. Demand for such diagnostic procedures is driven by healthcare needs, not the state of the economy, making CapsoVision's business non-cyclical.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company CapsoVision Inc
CapsoVision has developed an innovative capsule endoscopy system that provides a 360-degree view of the small intestine. This graph shows revenue expectations, which depend on the adoption of this technology by gastroenterologists and its ability to compete with existing solutions.
Future (predicted) profit of companies in the market segment - Diagnostic medical equipment
CapsoVision has developed an innovative capsule endoscopy system for small bowel examination that eliminates the need for external equipment. This chart shows the revenue forecast for the diagnostic medical equipment sector. It reflects expectations for more patient-friendly diagnostic procedures, a key driver of CapsoVision system sales.
Future (predicted) profit of the market as a whole
CapsoVision produces an innovative capsule endoscopic system for small bowel examination. Demand for its products depends on the budgets of medical institutions and the adoption of new technologies by physicians. The economic growth projected in the graph makes it easier for hospitals to invest in advanced diagnostic equipment.
P/S of the company, segment and market as a whole
P/S - CapsoVision Inc
CapsoVision has developed an innovative capsule endoscopy system for examining the small intestine. The patient swallows a capsule containing a camera that takes images without the need for an invasive procedure. This chart shows how investors view its technology and its ability to compete in the medical diagnostics market.
P/S market segment - Diagnostic medical equipment
CapsoVision has developed an innovative capsule endoscopy system. Patients swallow a small capsule containing a camera that takes images of the small intestine, helping doctors diagnose diseases without invasive procedures. This chart shows the average rating in the sector, providing insight into how the market views this patient-friendly diagnostic technology.
P/S of the market as a whole
CapsoVision has developed an innovative capsule endoscopy system that allows doctors to examine the small intestine without invasive procedures, simply by swallowing a capsule containing a camera. This chart compares the high revenue estimates of the medical technology company with the more mundane figures of traditional companies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company CapsoVision Inc
CapsoVision produces capsule endoscopes for gastrointestinal examination. Future revenue depends on the adoption of its technology in clinical practice. This chart shows how investors view the potential of this minimally invasive diagnostic method.
Future (projected) P/S of the market segment - Diagnostic medical equipment
CapsoVision Inc. likely develops diagnostic equipment, possibly in the field of gastroenterology (e.g., capsule endoscopy). This chart compares the company's estimated future sales with other diagnostic equipment manufacturers. It reflects investor expectations for its technology and its adoption by physicians.
Future (projected) P/S of the market as a whole
CapsoVision has developed innovative capsule endoscopy for esophageal examination. This is a less invasive diagnostic method. Market optimism, as reflected in this graph, is influencing healthcare systems' willingness to embrace new technologies that can improve patient comfort and potentially reduce costs compared to traditional procedures.
Sales of the company, segment and market as a whole
Company sales CapsoVision Inc
CapsoVision has developed an innovative capsule endoscopic system for small bowel examination that doesn't require bulky equipment. The company's revenue comes from sales of these disposable capsules to hospitals and clinics. The graph demonstrates the adoption of its convenient and effective diagnostic technology in medical practice.
Sales of companies in the market segment - Diagnostic medical equipment
CapsoVision has developed an innovative small bowel endoscopy system—the CapsoCam Plus capsule—with a 360-degree field of view. This allows physicians to obtain a more complete picture than competing products. Revenue is generated from the sale of these single-use capsules. This graph shows the growth of the minimally invasive gastrointestinal diagnostics market.
Overall market sales
CapsoVision produces an innovative capsule endoscopic system for gastrointestinal tract examination. The adoption of new medical technologies depends on their effectiveness and clinic budgets. This schedule, reflecting overall economic health, influences the healthcare system's ability to invest in modern diagnostic equipment.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company CapsoVision Inc
CapsoVision has developed an innovative capsule endoscopy that allows doctors to examine the small intestine without invasive procedures. The patient simply swallows a capsule containing a camera. This graph reflects analysts' expectations for the adoption of this less invasive diagnostic technology in gastroenterology.
Future (projected) sales of companies in the market segment - Diagnostic medical equipment
CapsoVision has developed an innovative capsule endoscopic system for small bowel examination. This chart illustrates expectations for the diagnostic equipment sector. It helps analyze how this unique technology, offering panoramic views, can change diagnostic standards and compete with existing solutions.
Future (projected) sales of the market as a whole
CapsoVision Inc. produces an innovative capsule endoscopy system that aids in the diagnosis of small bowel diseases. This graph, reflecting healthcare costs, is important to the company. Economic stability allows medical institutions to implement new, less invasive diagnostic technologies to improve patient comfort and outcomes.
Marginality of the company, segment and market as a whole
Company marginality CapsoVision Inc
CapsoVision revolutionized endoscopy by creating a capsule for gastrointestinal examination that requires no wires or bulky equipment. The company's business is selling innovative medical diagnostic devices. This chart illustrates how successfully the company is turning its unique technology into commercial and financial success.
Market segment marginality - Diagnostic medical equipment
CapsoVision has developed an innovative capsule endoscopy for small bowel examination. The patient swallows a capsule containing a camera. This graphic illustrates how their unique and less invasive diagnostic technology competes with traditional methods and how this impacts the company's operational efficiency in the medical device sector.
Market marginality as a whole
CapsoVision has developed an innovative capsule endoscopy system that allows doctors to examine the small intestine without invasive procedures. Overall profitability isn't their primary concern. Their business is a paradigm shift in gastroenterology. Profitability depends on physician adoption of their technology and expanded insurance coverage.
Employees in the company, segment and market as a whole
Number of employees in the company CapsoVision Inc
CapsoVision has developed an innovative capsule endoscopy system that eliminates the need for bulky equipment. This graph shows the team working on commercializing this technology. Staff growth will depend on the successful implementation of this product in gastroenterology practice.
Share of the company's employees CapsoVision Inc within the market segment - Diagnostic medical equipment
CapsoVision has developed an innovative capsule endoscopic system for small bowel examination that requires no external equipment. This graph shows its market share in the medical equipment niche. It reflects the team that created and promotes technology that makes diagnosing gastrointestinal diseases easier and more convenient for patients.
Number of employees in the market segment - Diagnostic medical equipment
CapsoVision has developed an innovative capsule endoscopic system for small bowel examination with a 360-degree field of view. This chart shows employment in the diagnostic equipment sector. The growth in employee numbers reflects efforts to commercialize this unique technology and implement it in gastroenterology practice worldwide.
Number of employees in the market as a whole
CapsoVision Inc. produces the innovative CapsoCam Plus endoscopic capsule for small bowel examination. Its unique feature is its 360-degree field of view, which eliminates the need for external equipment. This graph reflects overall employment, and medtech companies like CapsoVision exemplify how technology is improving diagnostics and creating jobs in manufacturing and sales.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company CapsoVision Inc (CV)
CapsoVision Inc. produces an endoscopic capsule for gastrointestinal tract examination. It is a high-tech medical business. This chart shows a high market capitalization per employee. The company's value is determined by its unique technology and patents. A small team of engineers and clinicians is creating a product that has the potential to transform medical diagnostics.
Market capitalization per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
CapsoVision has developed an innovative capsule endoscopy system for examining the small intestine. The patient simply swallows a capsule containing a camera. In the medical technology industry, this metric reflects the market valuation of a unique and patient-friendly product. The graph shows the premium investors place on the company's ability to transform diagnostic procedures.
Market capitalization per employee (in thousands of dollars) for the overall market
CapsoVision has developed an innovative capsule endoscopy system for small bowel examination that offers a 360-degree view. The company's value lies in its unique medical technology. This chart reflects how the market perceives the potential of this device for improving the diagnosis of gastrointestinal diseases.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company CapsoVision Inc (CV)
CapsoVision (CV) produces innovative capsule endoscopy—a "pill with a camera" for examining the gastrointestinal tract. It's a medical technology company. This chart shows how successfully the company is commercializing this technology. It measures how much revenue each employee (engineer, R&D, sales) generates.
Profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
CapsoVision produces an endoscopic capsule (CapsoCam Plus) with a 360-degree field of view, simplifying gastrointestinal diagnostics. Their business is medtech innovation. This chart shows the industry benchmark. It helps evaluate how effectively the CapsoVision team monetizes their unique diagnostic technology compared to medtech giants.
Profit per employee (in thousands of dollars) for the market as a whole
CapsoVision produces an innovative endoscopy system—a "camera in a capsule" (CapsoCam Plus), which the patient swallows for small bowel examination. It's a "razor and blade" model. Their profit per employee depends on how successfully their sales team convinces doctors to use their system, which leads to regular purchases of disposable capsules.
Sales to employees of the company, segment and market as a whole
Sales per company employee CapsoVision Inc (CV)
CapsoVision produces an innovative capsule endoscopic system for small bowel examination. This chart shows the commercialization of this new medical device. Growth in revenue per employee will reflect the company's success in convincing doctors and clinics to adopt their convenient and non-invasive technology.
Sales per employee in the market segment - Diagnostic medical equipment
CapsoVision (CV) is a medical technology company that developed the CapsoCam Plus, a 360-degree capsule endoscopic system for diagnosing gastrointestinal diseases. This graph shows the revenue generated by each employee from capsule sales. It is an indicator of the commercialization of their diagnostic technology.
Sales per employee for the market as a whole
CapsoVision Inc (CV) is a company that produces innovative capsule endoscopy devices. The patient swallows a capsule (CapsoCam) that takes 360-degree images of the gastrointestinal tract. It's a medical device. This chart shows how successfully their team generates revenue by selling these "disposable" diagnostic capsules to gastroenterologists as an alternative to traditional colonoscopy.
Short shares by company, segment and market as a whole
Shares shorted by company CapsoVision Inc (CV)
CapsoVision (CV) – (Note: Likely privately held or little known). The company produces an endoscopic capsule for gastrointestinal examination. This chart shows bearish bets. Shorts in this segment may be due to their technology failing to replace traditional colonoscopy due to lower accuracy or reimbursement issues.
Shares shorted by market segment - Diagnostic medical equipment
CapsoVision (CV) is a medical technology company that produces an endoscopic capsule (CapsoCam) for small bowel imaging. This chart shows bets against the MedTech sector. The rising bets against the industry reflect investor concerns about strong competition from the market leader (Medtronic) and difficulties in receiving reimbursement from insurers.
Shares shorted by the overall market
CapsoVision produces innovative diagnostic equipment (capsule endomicroscopy). Medical diagnostics are always necessary. However, implementing *new* technologies requires capital expenditures from hospitals. When general economic fears (as shown in this chart) are high, hospitals often freeze budgets for new equipment purchases to conserve cash.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator CapsoVision Inc (CV)
CapsoVision (CV) is a speculative stock in the medical technology sector. When this general fear indicator rises (<30), investors sell small, illiquid, and unprofitable companies. This CV chart reflects the general panic/euphoria in the sector rather than the specifics of the business. The >70 zone is rare hype.
RSI 14 Market Segment - Diagnostic medical equipment
CapsoVision is the manufacturer of CapsoCam, an innovative endoscopic capsule that the patient swallows for a 360-degree view of the gastrointestinal tract. It competes with traditional endoscopy. This chart tracks the collective sentiment in the diagnostic medical equipment sector. It helps assess how investors view this niche and how CV compares to it.
RSI 14 for the overall market
CapsoVision (CV) produces medical equipment. This chart shows that its business is "defensive." Demand for its products isn't driven by euphoria or panic—it's driven by the need for diagnostics. During times of market panic, investors seek safe havens in companies with non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CV (CapsoVision Inc)
CapsoVision is a medical device company known for its CapsoCam Plus, a small bowel endoscopy capsule that provides 360-degree imaging. This chart shows the average analyst price target, reflecting their expectations for gastroenterologists' adoption of this technology.
The difference between the consensus estimate and the actual stock price CV (CapsoVision Inc)
CapsoVision (CV) is a medical technology company that developed CapsoCam, an innovative endoscopic capsule (pill-shaped camera) with a 360-degree field of view for gastrointestinal diagnostics. This chart shows the difference between the consensus forecast and the price. It reflects analysts' confidence in this niche diagnostic technology and its potential.
Analyst consensus forecast for stock prices by market segment - Diagnostic medical equipment
CapsoVision (CV) stands for "endoscopy in a capsule." The company produces a ingestible camera (CapsoCam Plus) that takes 360-degree images of the gastrointestinal tract, replacing invasive procedures. This chart shows analysts' overall expectations for the diagnostic equipment sector. It reflects whether experts believe the non-invasive diagnostics and telemedicine market will grow.
Analysts' consensus forecast for the overall market share price
CapsoVision is a "medtech" company that "produces" "innovative" "capsules" "for" "endoscopy" (a camera "instead of" a "probe"). This chart of overall market sentiment is important. "Optimism" = "hospitals" are "actively" "investing" in "expensive" "new" "equipment" and "willing" to "try" "new" "technologies." "Pessimism" = "freezing" "capital" "expenditures."
AKIMA index of the company, segment and market as a whole
AKiMA Company Index CapsoVision Inc
CapsoVision (CV) is a medical technology company that has simplified endoscopy. They produce a capsule endoscope (CapsoCam)—a swallowable camera that films the inside of the gastrointestinal tract without the traditional tube. This chart is an adoption indicator. It measures their ability to convince doctors and patients to use their (less invasive) technology instead of the gold standard, colonoscopy.
AKIMA Market Segment Index - Diagnostic medical equipment
CapsoVision is a medical device company that developed an innovative capsule endoscopy system (CapsoCam), which provides a 360-degree view of the gastrointestinal tract. This chart shows the average index for the diagnostics sector. It helps investors understand how CapsoVision's technology outperforms the industry average.
The AKIM Index for the overall market
CapsoVision is a developer of a capsule endoscopy system for small bowel diagnostics. It offers an alternative to traditional procedures. This chart, reflecting the market average, is just a backdrop. It helps assess how this niche MedTech company, competing with giants, stacks up against overall macroeconomic trends in diagnostics.